China Resources Pharmaceutical Holdings

China Resources Pharmaceutical Group is a leading integrated pharmaceutical company in China, operating across the entire industry value chain including R&D, manufacturing, distribution, and retail. As a subsidiary of the state-owned China Resources (Holdings), the company manages a diverse portfolio of well-known brands such as 999, Double-Crane, and Dong-E-E-Jiao. Its product offerings span chemical drugs, traditional Chinese medicine, biologics, and nutritional supplements, with a strong market presence in cardiovascular, alimentary tract, and oncology treatments. The group also operates one of the largest pharmaceutical distribution networks in China, providing logistics and supply chain services to thousands of hospitals and retail pharmacies. With a focus on innovation and strategic acquisitions, the company continues to expand its footprint in high-growth areas like biosimilars and plasma-derived therapies.